Abstract:Background: Patients with alcoholic hepatitis (AH) often have serious complication burden including hepatic encephalopathy, jaundice, and ascites, and those with severe disease have a poor prognosis.To address symptom management and goals of care discussions, patients may benefit from palliative care (PC).However, the role of PC in the management of AH has not been described.We sought to identify factors associated with PC consults and the association between PC and healthcare utilization in patients with AH.Methods: In this cohort study, consecutive patients with AH admitted to Indiana University-affiliated hospitals from 1/2017 to 2/2021 were followed for 90-day outcomes.Those with and without PC consults were compared.Demographic and clinical variables including measures of disease severity were recorded.Outcomes included the number of inpatient procedures, advanced directive completion, 90-day readmissions, and mortality.Multivariable logistic regression was used to identify factors independently associated with PC consult.Results: 236 patients with AH were included, of whom 37 saw PC (16%).81% of PC consults were primarily for goals of care discussion, and 16% were for symptom management.Those seen by PC were older (49 vs 43 years, p=0.004) with higher Model for End-Stage Liver Disease-Sodium score (28 vs 25), Charlson comorbidity index (3 vs 1), and discriminant function (69 vs 44, p<0.001 for all).21% of those with discriminant function $32 saw PC.Patients who saw PC were more likely to have encephalopathy, ascites, acute kidney injury, and acuteon-chronic liver failure (ACLF).However, use of steroids and response to steroids were similar in both groups.Patients seen by PC were more likely to undergo procedures in the hospital, had longer length of stay, and greater mortality.90-day readmission rates were similar between groups.Patients who saw PC were more likely to place limits on code status and to complete advanced care planning forms.In multivariable logistic regression, PC was positively associated with Charlson comorbidity index (OR 1.3, p=0.010),ACLF (OR 3.9, p=0.002), discriminant function $32 (OR 1.9, p=0.197), and dialysis on admission (OR 8.26, p=0.070).Conclusion: Despite high complication burden and poor outcomes, PC is underutilized.PC consults were performed for those with more severe disease and poorer short-term outcomes.Those seen by PC were more likely to place limits on code status and to complete healthcare representative forms.PC aids patients and medical teams in goals of care discussions and may have a valuable role in optimizing care for patients with AH.Table 1.Cohort characteristics and differences between those who were seen by PC and those that were not Mo1330

Impact of Karnofsky performance status on outcomes of patients with severe alcohol‐associated hepatitis: a propensity‐matched analysis

Association of Karnofsky Performance Status with liver transplant outcomes in hepatocellular carcinoma

A Prognostic Evaluation and Management of Alcoholic Hepatitis

Relationship between updated MELD and prognosis in alcohol-associated hepatitis: Opportunities for more efficient trial design

Determinants of long-term outcome in severe alcoholic hepatitis

Age added to MELD or ACLF predicts survival in patients with alcohol-associated hepatitis declined for liver transplantation

Multicentered study of patient outcomes after declined for early liver transplantation in severe alcohol-associated hepatitis

Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: A worldwide study

P-19 CHARACTERIZATION, PROGNOSTIC FACTORS, AND SURVIVAL IN MODERATE ALCOHOL-ASSOCIATED HEPATITIS: A MULTICENTER STUDY

Impact of Metabolic Risk Factors on the Severity and Outcome of Patients with Alcohol-Associated Acute-on-chronic Liver Failure.

Outcomes of patients with alcohol-associated hepatitis and acute kidney injury - Results from the HRS Harmony Consortium

Expedited liver transplantation as first‐line therapy for severe alcohol hepatitis: ELFSAH; deferring corticosteroids in the sickest subset of patients

Evolving trends and outcomes on the US liver transplant waitlist of alcohol‐associated hepatitis patients with very high MELD scores

Utility of Lille Score in Predicting 30-Day Survival in Steroid-Treated Alcohol-Associated Hepatitis

Survival benefit from corticosteroids in severe alcohol-associated hepatitis attributed to clinical and treatment differences in a large multicenter cohort

The impact of Karnofsky performance status on prognosis of patients with hepatocellular carcinoma in liver transplantation

P- 40 PENTOXIFYLLINE USE IN PATIENTS WITH ALCOHOL-ASSOCIATED HEPATITIS ADMITTED WITH ACUTE KIDNEY INJURY COULD DECREASE SURVIVAL: A GLOBAL STUDY

Demographic inequities exist and influence transplant outcomes in liver transplantation for acute alcohol-associated hepatitis

G‐CSF—In Patients With Severe Alcohol‐Associated Hepatitis: A Real‐World Experience

Mo1330: THE IMPACT OF COVID-19 ON ALCOHOLIC LIVER DISEASES IN A PREDOMINANTLY AFRICAN AMERICAN AND HISPANIC COMMUNITY

Outcomes of Early Liver Transplantation for Patients With Severe Alcoholic Hepatitis